Showing results (111-120 of 203) with videos related to

Sort By:
Pageof 21
Arthritis & Rheumatology (Hoboken, N.J.)|July 9, 2026
Non-melanoma skin cancer risk with Janus kinase inhibitors compared to interleukin-6 receptor inhibitors in rheumatoid arthritis: results from a national cohort studyZixing Tian, Lianne Kearsley-Fleet, Sizheng Steven Zhao, et al.
RMD Open|November 16, 2016
Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritisLianne Kearsley-Fleet, Flora McErlane, Helen E Foster, et al.
International Journal of Clinical Practice|April 20, 2020
Controlling antibiotic usage-A national analysis of General Practitioner/Family Doctor practices links overall antibiotic levels to demography, geography, comorbidity factors with local discretionary prescribing choicesMichael Stedman, Mark Lunt, Mark Davies, et al.
The American Journal of Clinical Nutrition|August 10, 2005
Dietary beta-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective studyDorothy J Pattison, Deborah P M Symmons, Mark Lunt, et al.
Rheumatology (Oxford, England)|August 24, 2016
The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid ArthritisLucía Silva-Fernández, Mark Lunt, Lianne Kearsley-Fleet, et al.
Rheumatology (Oxford, England)|July 11, 2023
Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021Yun-Ting Huang, David A Jenkins, Belay Birlie Yimer, et al.
Rheumatology (Oxford, England)|October 3, 2017
Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid ArthritisLucía Silva-Fernández, Diederik De Cock, Mark Lunt, et al.
International Journal of Clinical Practice|May 21, 2020
The treatment rate of erectile dysfunction (ED) in younger men with type 2 diabetes is up to four times higher than the equivalent non-diabetes populationMike Stedman, Martin B Whyte, Mark Lunt, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|February 5, 2003
Predictors of hip joint replacement in new attenders in primary care with hip painFraser Birrell, Cara Afzal, Elizabeth Nahit, et al.
Arthritis and Rheumatism|May 18, 2004
A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritisRachelle Donn, Zaynab Alourfi, Eleftheria Zeggini, et al.
Pageof 21